Clinical Trial Update: Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia

View source ↗

Summary

Clinical trial update evaluating procalcitonin levels at baseline and at 24 hours as prognostic factors in pneumonia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Snippet

Sponsor: Corewell Health South | Conditions: Pneumonia | Status: COMPLETED